← Open Payments lookup

MICHAEL SANTILLAN: Open Payments

NPI 1861139628 · MISSION VIEJO, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$876 in 36 payments from 14 companies in 2025. Trend: 2023 $4,150 · 2024 $4,820 · 2025 $876

Food & beverage: $876
CompanyPaymentsAmount
Vanda Pharmaceuticals Inc.5$157
Janssen Pharmaceuticals, Inc4$127
Alkermes, Inc.4$95
ABBVIE INC.5$85
Supernus Pharmaceuticals, Inc.3$69
E.R. Squibb & Sons, L.L.C.2$67
Neurocrine BioSciences, Inc.2$54
Otsuka America Pharmaceutical, Inc.3$50
Lundbeck LLC2$50
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)2$42

Products named: HETLIOZ, SPRAVATO, REXULTI, ARISTADA, VRAYLAR, COBENFY, INGREZZA, CAPLYTA.

Industry payments across CA — which companies pay providers there.